Enhances Company’s Presence Across the New York Metro Region as Demand for Clean-Label, Better-For-You Foods Continues to GrowBELVIDERE, NJ, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leading provider of controlled environment agriculture (CEA) solutions and sustainable, locally grown organic produce, today announced that Pickle Party™ shipments are now underway to King Kullen supermarkets. The introduction brings the Company’s ...

Core Insights - LZ Technology Holdings Limited has entered into a partnership with Red Dune Capital Holding Limited to establish its regional headquarters in the MENA region and commercialize its smart access control systems and IoT technologies [1][2][4] - This partnership signifies the launch of LZ Technology's global second growth curve, aiming to replicate its successful business model from China in the MENA region [2][4] - The MENA region is experiencing rapid growth in smart-city development and digital infrastructure investment, creating a favorable environment for LZ Technology's expansion [2][4] Company Strategy - The collaboration aims to build a full-scale operational platform in MENA, focusing on smart access control, community-service digitalization, and integrated business-service ecosystems [2][3] - LZ Technology plans to leverage Red Dune's extensive local networks and capital capabilities to accelerate its expansion in the Middle East [3][4] - The goal is to create "another LZ Technology" in the MENA region, establishing a strong regional presence and a second global growth engine [4] Market Potential - The MENA region is witnessing strong growth in urban digital governance, property management modernization, and digital public service upgrades, indicating a robust market potential for LZ Technology [2][4] - LZ Technology intends to progressively expand into key markets such as Saudi Arabia, Qatar, Kuwait, and Egypt, aiming to build a region-wide smart-community digital network [4] Company Overview - LZ Technology operates primarily in three verticals: Smart Community, Out-of-Home Advertising, and Local Life, providing intelligent access control and safety management systems across thousands of residential communities in China [5] - The Out-of-Home Advertising division offers multi-channel advertising solutions through a vast network of monitors in approximately 120 cities in China [5]

Core Insights - Toro Corp. reported its financial results for the third quarter and nine months ended September 30, 2025, highlighting a stable performance despite some declines in revenue and net income compared to the previous year [1][2]. Financial Performance - Third Quarter - Total vessel revenues from continuing operations increased to $5.4 million, a 1.9% increase from $5.3 million in the same period of 2024 [5][6]. - Net income from continuing operations rose to $1.3 million, reflecting a 30% increase from $1.0 million in the third quarter of 2024 [5][6]. - EBITDA from continuing operations was $1.6 million, compared to a loss of $0.1 million in the same period last year [5][6]. - The average Daily TCE Rate improved to $13,363 from $11,426 in the same period of 2024 [6][41]. Financial Performance - Nine Months - Total vessel revenues from continuing operations decreased to $15.0 million, a 12.8% decline from $17.2 million for the nine months ended September 30, 2024 [5][28]. - Net income from continuing operations was $4.2 million, down 6.7% from $4.5 million in the same period last year [5][28]. - Net income overall dropped significantly to $4.3 million, an 82.2% decrease from $24.2 million for the nine months ended September 30, 2024 [5][28]. - EBITDA for the nine months was $3.8 million, up from $1.7 million in the same period of 2024 [5][28]. Operational Developments - The company acquired two MR tanker vessels and sold two LPG carriers during the third quarter, indicating ongoing fleet management activities [4]. - The spin-off of the Handysize tanker segment to Robin Energy Ltd. was completed on April 14, 2025 [5]. Cash Flow and Liquidity - Cash position decreased by $12.1 million to $25.1 million as of September 30, 2025, primarily due to net operating cash flows used in continuing operations and financing activities [15][38]. - The company made a capital contribution of $10.4 million to Robin in connection with the spin-off [15]. Recent Business Developments - On October 15, 2025, Toro received dividends from Castor and Robin, amounting to $1.25 million and $0.125 million, respectively [16]. - An "at-the-market" offering agreement was established on November 13, 2025, allowing the company to sell common shares valued up to $12.5 million for various corporate purposes [18].

Core Insights - Jeffs' Brands Ltd has entered into a distribution agreement with Scanary Ltd, marking its strategic entry into the global homeland-security sector [1][2] Company Overview - Jeffs' Brands is a data-driven e-commerce company focused on transforming products into market leaders through advanced technology and management insights [4] Agreement Details - KeepZone AI Inc., a subsidiary of Jeffs' Brands, will market and distribute Scanary's AI-radar screening systems, which can scan up to 25,000 people per hour without stopping [2] - The agreement includes a one-time payment of $1 million to Scanary, payable in five monthly installments of $200,000 [3] - Scanary will provide a free demonstration unit and technical support for pre-sales activities [3] Market Potential - The security scanning equipment market was valued at over $11.4 billion in 2022 and is expected to grow at a CAGR of over 7% from 2023 to 2032 [3] Distribution Rights - KeepZone has exclusive distribution rights for the systems in Canada, Germany, and the UAE for an initial 24-month period, extendable upon achieving a purchase target of 20 systems [6] - Non-exclusive distribution rights are granted in Spain and Italy [6]

Core Insights - CG Oncology, Inc. announced promising topline data from BOND-003 Cohort P and CORE-008 Cohort A, indicating efficacy, safety, and tolerability of cretostimogene for bladder cancer treatment [1][2][3] BOND-003 Cohort P Results - The BOND-003 trial demonstrated High-Grade Event-Free Survival (HG-EFS) rates of 95.7% at 3 months, 84.6% at 6 months, and 80.4% at 9 months among 51 evaluable patients [4][9] - No Grade 3 or greater treatment-related adverse events (TRAEs) were reported, and no patients progressed to muscle-invasive bladder cancer (MIBC) [5][9] - The study included 56 patients across 35 clinical sites in the U.S. and Japan [6] CORE-008 Cohort A Results - CORE-008 Cohort A showed an overall Complete Response (CR) rate of 83.7% in evaluable patients, with an 88.0% CR rate for optimized administration compared to 79.2% for original administration [7][10] - The safety profile was consistent with previous trials, with no serious adverse events or treatment-related discontinuations reported [8][10] Cretostimogene Overview - Cretostimogene is an investigational oncolytic immunotherapy for Non-Muscle Invasive Bladder Cancer (NMIBC), with over 400 patients involved in its clinical development [11] - The company is conducting two Phase 3 trials: BOND-003 for high-risk BCG-unresponsive NMIBC and PIVOT-006 for intermediate-risk NMIBC [11] Company Background - CG Oncology focuses on developing and commercializing bladder-sparing therapies for bladder cancer patients, aiming to improve their quality of life [12]

Core Viewpoint - Lead Real Estate Co., Ltd will participate in Sidoti & Company's Year End Virtual Investor Conference on December 10-11, 2025, with a presentation scheduled for December 11 at 10:00 a.m. ET [1][2][3] Company Overview - Lead Real Estate Co., Ltd is a Japanese developer specializing in luxury residential properties, including single-family homes and condominiums, primarily in Tokyo, Kanagawa prefecture, and Sapporo [4] - The company also operates the ENT TERRACE brand of extended-stay hotels and leases apartment units in Japan and Dallas, Texas [4] Conference Participation Details - The conference will take place virtually on December 10-11, 2025, with a corporate presentation by Eiji Nagahara and Daisuke Takahashi on December 11 from 10:00 a.m. to 10:30 a.m. ET [3] - One-on-one meetings with investors will be available throughout both days of the conference [3] Company Mission and Vision - The company's mission is to provide stylish, safe, and luxurious living [5] - It aims to adopt a Kaizen approach for continuous improvement and leverage its strong market position in luxury residential properties to create a global transaction platform for prime Japanese and overseas condominiums [5] Brand Recognition - The ENT TERRACE brand has received accolades, including the "Luxury Apartments of the Year in Kanto" at the Travel & Hospitality Awards 2025, highlighting its service excellence in the international tourism industry [7][8]

Core Insights - Soligenix Inc. is a late-stage biopharmaceutical company focused on developing therapies for rare diseases with significant unmet medical needs [3][4] - The U.S. healthcare system faces increasing challenges from chronic illnesses and rare disorders, particularly among older populations, with over 30 million Americans affected by rare diseases [2][3] - Soligenix is advancing several therapies, including HyBryte(TM) for cutaneous T-cell lymphoma, and is positioned to align with national healthcare goals under the current administration [3][4] Company Overview - Soligenix Inc. specializes in developing and commercializing products for rare diseases, with a focus on HyBryte(TM) as a novel photodynamic therapy for cutaneous T-cell lymphoma [4] - The company is also expanding its pipeline to include treatments for psoriasis and inflammatory diseases, as well as vaccine candidates for bioterrorism threats and COVID-19 [5] Industry Context - The increasing burden of rare diseases among aging populations highlights the urgent need for innovative treatments, as many conditions lack FDA-approved therapies [2][3] - The company's initiatives are supported by government grants and contracts from agencies such as NIAID, DTRA, and BARDA, indicating a strong alignment with public health objectives [5]

Core Insights - Lexicon Pharmaceuticals, Inc. announced the presentation of clinical data on adipose tissue distribution in non-diabetic patients treated with sotagliflozin at the 22nd Global Cardio Vascular Clinical Trialists Forum (CVCT 2025) [1] - The data comes from the SOTA-P-CARDIA trial, which focused on patients with heart failure with preserved ejection fraction (HFpEF) [2] - Craig Granowitz, M.D., Ph.D., highlighted that the new data supports sotagliflozin's differentiated benefits compared to SGLT2 inhibitors [3] Sotagliflozin Overview - Sotagliflozin is an oral inhibitor of SGLT2 and SGLT1, which are involved in glucose regulation [4] - The drug has been studied in various patient populations, including approximately 20,000 patients across heart failure, diabetes, and chronic kidney disease [4] - Sotagliflozin is also under investigation for hypertrophic cardiomyopathy (HCM) [4] Company Background - Lexicon Pharmaceuticals aims to pioneer medicines that transform patients' lives through its Genome5000™ program, which has identified over 100 protein targets with therapeutic potential [5] - The company has a pipeline of drug candidates in various stages of development, focusing on neuropathic pain, HCM, metabolism, and other indications [5]

Core Insights - Alpha Modus Holdings, Inc. has signed a pilot agreement with a major national retail chain to deploy approximately 100 AlphaCash financial service kiosks across Texas, marking the first entry of AlphaCash into retail stores [1][4] - The pilot aims to address the needs of underbanked consumers, with a significant portion of the population in areas like Houston being underbanked [4][6] - Alpha Modus has identified over 4,000 additional U.S. retail locations for potential expansion of AlphaCash, contingent on the pilot's success [3][7] Company Strategy - The pilot represents a material inflection point for Alpha Modus's financial services platform, with a conservative estimate of $2,000 in monthly revenue per kiosk [4] - The rollout will include coordinated joint-marketing efforts between Alpha Modus and the retailer, providing a unified public launch strategy [1][6] - AlphaCash kiosks will initially offer services such as Check Cashing, Money Transfer, Event Tickets, and Mobile Top-Up, with plans for additional services as adoption increases [5][6] Market Opportunity - The underbanked population in the U.S. is estimated at 4.2% of households, indicating a substantial market opportunity for accessible financial services [4] - The pilot will span both rural and metropolitan regions, targeting areas with high concentrations of underbanked consumers [1][4] - Alpha Modus is positioned for accelerated national-scale growth and expanded financial-access impact, leveraging its AI-driven fintech platform [7]

Core Viewpoint - XBP Global Holdings, Inc. has announced a 1-for-10 reverse stock split, effective December 12, 2025, to enhance its stock price and market perception [1][2]. Group 1: Reverse Stock Split Details - The reverse stock split was authorized by stockholders at the Annual Meeting on July 25, 2025, where every ten shares will be combined into one share [2]. - No fractional shares will be issued; stockholders entitled to fractional shares will receive cash based on the closing price on the effective date [2]. - Post-split, XBP Global will have approximately 11.75 million shares of common stock outstanding, with adjustments made to outstanding warrants, stock options, and other derivative securities [3]. Group 2: Company Overview - XBP Global is a multinational technology and services company specializing in intelligent workflows, with operations in 20 countries and around 11,000 employees [5]. - The company partners with over 2,500 clients, including many Fortune 100 companies, to facilitate hyper-automation and digital transformation [5][6].